Breaking News

Thermo Fisher Scientific expands its SARS-CoV-2 testing portfolio in India with a point-of-care testing platform

The Accula System is an innovative platform that will accelerate the availability of reliable and accurate advanced molecular diagnostics at the point of care.

Mumbai (Maharashtra) [India], June 15: Thermo Fisher Scientific today announced the introduction of the new and innovative Accula SARS-CoV-2 Test that delivers gold-standard reverse transcription-polymerase chain reaction (RT-PCR) detection of SARS-CoV-2 in a point-of-care format.

The Accula SARS-CoV-2 Test has received Emergency Use Authorization (EUA) from the United States (U.S.) Food and Drug Administration (FDA) for the detection of SARS-CoV-2 in Clinical Laboratory Improvement Amendments (CLIA)–waived environments.

“Since the start of the pandemic, Thermo Fisher has acted quickly to provide support to the scientists and healthcare professionals at the frontlines of combating COVID-19,” said Amit Chopra, Managing Director, India, and South Asia, Thermo Fisher Scientific. “Thermo Fisher’s new testing platform combines the accuracy of RT-PCR with the simplicity, convenience, and procedural familiarity of traditional rapid immunoassays. The Accula SARS-CoV-2 Test is a natural extension to our existing offerings and will significantly help to meet the continuing demands for rapid and reliable COVID-19 testing in India.”

RT-PCR testing is streamlined from start to finish using a fully integrated, single-use microfluidic test cassette and the reusable, palm-sized Accula Dock. The test uses nasal swab samples and provides reliable, qualitative results in approximately 30 minutes. The Accula SARS-CoV-2 Test is enabled by proprietary PCR technology that allows for reduced absolute temperatures and reduced temperature differentials—resulting in rapid exponential amplification while reducing overall thermocycling times.

“The rapid Accula point-of-care test will open new avenues of personal and public testing without compromising on accuracy,” added Amit. “The introduction of the test in India is a demonstration of the impact our solutions have on human health during the pandemic, and far beyond.”

In January 2021, Thermo Fisher acquired Mesa Biotech Inc., which developed the Accula SARS-CoV-2 Test to provide accurate and faster results at the point of care.

For more information, please visit www.thermofisher.com

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $30 billion. Our Mission is to enable our customers to make the world healthier, cleaner, and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies, or increasing productivity in their laboratories, we are here to support them. Our global team of more than 80,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience, and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, and Patheon.

Average Rating

5 Star
0%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

8 thoughts on “Thermo Fisher Scientific expands its SARS-CoV-2 testing portfolio in India with a point-of-care testing platform

  1. [url=https://viagra150mgrx.quest/]can you purchase viagra over the counter in mexico[/url] [url=https://ordercialistabnorx.quest/]generic cialis in usa[/url] [url=https://cheapviagra200norx.quest/]female viagra for sale online[/url] [url=https://orderviagramedicationrx.monster/]can i buy viagra online in usa[/url] [url=https://viagrabestdrugstore.monster/]female viagra in australia[/url] [url=https://onlineviagrageneric.quest/]canadian pharmacy viagra prices[/url] [url=https://cialisbestpillsonlinedrugstore.quest/]cialis tadalafil 20mg[/url] [url=https://buycialiswithoutrx.monster/]cialis viagra online[/url] [url=https://bestcialismedicationprescription.monster/]cialis 20 mg tablet price[/url] [url=https://cialis5tablets.monster/]cialis for sale without prescription[/url]

  2. 521566 271710woah i like yur site. It genuinely helped me with the information i wus seeking for. Appcriciate it, will bookmark. 682229

  3. Bonuses and rewards are the most important part of the whole casino experience. The selection of games might act as a pull for players, but the quality of bonuses ensures they stay. The 25 Free Spins No Deposit Bonus is one of the most in-demand bonus in the online gambling world is. Keeping true to its namesake this bonus reward indeed needs no first deposit to be made, players just need to start spinning the wheels to set it in motion. There’s also a Game of the Month promotions, for April 2019 players can enter the Slots Empire Casino Bonus Code “Happiness” and receive either a 115% match-bonus with an additional sixty free spins or a 145% match bonus with 80 free spins. The game selected for this monthly bonus is Trigger Happy. We recommend reading over the terms and conditions of each bonus to guarantee it suits your play style. https://forum.zacasniodvzem.si/profile/verenamargarot/ No. In general, a no deposit bonus casino will only allow new customers one promotion each. For example, blackjack bonuses are exceedingly rare while online slots bonuses are almost always included in online casino signup offers. Most gambling sites only count a small percentage of every blackjack wager toward the wagering requirements. Fortunately, blackjack is such a low house advantage game that many casino deposit bonuses can be successfully cleared with blackjack if players use proper playing strategy. These casinos shouldn’t be confused with social casinos like High 5 Casino or Chumba Casino. Whereas social casinos are just for fun, sweepstakes casinos allow you to win real cash. However, they use a combination of two legal technicalities to fall under sweepstakes law rather than gambling per se. There are also sweepstakes poker sites using the same technique.

Leave a Reply

Your email address will not be published.